TreeWAS – Variant ID: rs11001819

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.5 Disorders of calcium metabolism	0.000	0.464	0.536
E83 Disorders of mineral metabolism	0.000	0.970	0.030
N18.9 Chronic renal failure, unspecified	0.029	0.971	0.000
E83.8 Other disorders of mineral metabolism	0.000	0.978	0.021
E83.2 Disorders of zinc metabolism	0.000	0.978	0.021
E83.0 Disorders of copper metabolism	0.000	0.978	0.021
F20.9 Schizophrenia, unspecified	0.020	0.980	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.980	0.019
E83.1 Disorders of iron metabolism	0.000	0.981	0.019
F20 Schizophrenia	0.019	0.981	0.000
F20.0 Paranoid schizophrenia	0.016	0.984	0.000
F20.8 Other schizophrenia	0.016	0.984	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.016	0.984	0.000
F29 Unspecified nonorganic psychosis	0.016	0.984	0.000
G30.9 Alzheimer's disease, unspecified	0.014	0.986	0.000
T42.4 Benzodiazepines	0.014	0.986	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.014	0.986	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.014	0.986	0.000
F20.6 Simple schizophrenia	0.014	0.986	0.000
F20.4 Postschizophrenic depression	0.014	0.986	0.000
F20.3 Undifferentiated schizophrenia	0.014	0.986	0.000
F20.2 Catatonic schizophrenia	0.014	0.986	0.000
F20.1 Hebephrenic schizophrenia	0.014	0.986	0.000
F23 Acute and transient psychotic disorders	0.013	0.987	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.013	0.987	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.013	0.987	0.000
F25 Schizoaffective disorders	0.013	0.987	0.000
T40.6 Other and unspecified narcotics	0.012	0.988	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.012	0.988	0.000
T40.4 Other synthetic narcotics	0.012	0.988	0.000
T42.1 Iminostilbenes	0.012	0.988	0.000
F28 Other nonorganic psychotic disorders	0.012	0.988	0.000
F24 Induced delusional disorder	0.012	0.988	0.000
F21 Schizotypal disorder	0.012	0.988	0.000
F25.1 Schizoaffective disorder, depressive type	0.011	0.988	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.989	0.011
F20.5 Residual schizophrenia	0.011	0.989	0.000
T40.5 Cocaine	0.011	0.989	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.011	0.989	0.000
T36 Poisoning by systemic antibiotics	0.011	0.989	0.000
F25.2 Schizoaffective disorder, mixed type	0.011	0.989	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.011	0.989	0.000
T40.1 Heroin	0.011	0.989	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.011	0.989	0.000
T40.2 Other opioids	0.011	0.989	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.011	0.989	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.011	0.989	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.011	0.989	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.011	0.989	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.011	0.989	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.010	0.990	0.000
T42.3 Barbiturates	0.010	0.990	0.000
T42.2 Succinimides and oxazolidinediones	0.010	0.990	0.000
G30 Alzheimer's disease	0.010	0.990	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.010	0.990	0.000
T40.8 Lysergide [LSD]	0.010	0.990	0.000
T40.7 Cannabis (derivatives)	0.010	0.990	0.000
T40.0 Opium	0.010	0.990	0.000
J38.7 Other diseases of larynx	0.000	0.990	0.010
F23.9 Acute and transient psychotic disorder, unspecified	0.010	0.990	0.000
F23.8 Other acute and transient psychotic disorders	0.010	0.990	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.010	0.990	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.010	0.990	0.000
T42.0 Hydantoin derivatives	0.010	0.990	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.010	0.990	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.010	0.990	0.000
F25.8 Other schizoaffective disorders	0.010	0.990	0.000
T40.3 Methadone	0.010	0.990	0.000
T47.4 Other laxatives	0.009	0.990	0.000
T36.3 Macrolides	0.009	0.991	0.000
T36.4 Tetracyclines	0.009	0.991	0.000
T43.6 Psychostimulants with abuse potential	0.009	0.991	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.009	0.991	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.009	0.991	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.009	0.991	0.000
T43.9 Psychotropic drug, unspecified	0.009	0.991	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
G30.8 Other Alzheimer's disease	0.009	0.991	0.000
T36.8 Other systemic antibiotics	0.009	0.991	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.009	0.991	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.009	0.991	0.000
G30.0 Alzheimer's disease with early onset	0.009	0.991	0.000
F22 Persistent delusional disorders	0.009	0.991	0.000
T46.1 Calcium-channel blockers	0.009	0.991	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.008	0.991	0.000
T47.2 Stimulant laxatives	0.008	0.991	0.000
T36.9 Systemic antibiotic, unspecified	0.008	0.992	0.000
T36.7 Antifungal antibiotics, systemically used	0.008	0.992	0.000
T36.6 Rifamycins	0.008	0.992	0.000
T36.5 Aminoglycosides	0.008	0.992	0.000
T36.2 Chloramphenicol group	0.008	0.992	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.008	0.992	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.008	0.992	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.008	0.992	0.000
T46.7 Peripheral vasodilators	0.008	0.992	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.008	0.992	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.008	0.992	0.000
T36.0 Penicillins	0.008	0.992	0.000
F25.0 Schizoaffective disorder, manic type	0.008	0.992	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.008	0.992	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.008	0.992	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.008	0.992	0.000
T47.7 Emetics	0.008	0.992	0.000
T47.6 Antidiarrhoeal drugs	0.008	0.992	0.000
T47.5 Digestants	0.008	0.992	0.000
T47.3 Saline and osmotic laxatives	0.008	0.992	0.000
T92.1 Sequelae of fracture of arm	0.000	0.992	0.008
T43.4 Butyrophenone and thioxanthene neuroleptics	0.008	0.992	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.008	0.992	0.000
T47.0 Histamine H(2)-receptor antagonists	0.008	0.992	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.008	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.992	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.008	0.992	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.008	0.992	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.008	0.992	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.008	0.992	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.992	0.000
T37.5 Antiviral drugs	0.008	0.992	0.000
T37.4 Anthelminthics	0.008	0.992	0.000
T37.3 Other antiprotozoal drugs	0.008	0.992	0.000
T37.1 Antimycobacterial drugs	0.008	0.992	0.000
T37.0 Sulphonamides	0.008	0.992	0.000
F25.9 Schizoaffective disorder, unspecified	0.008	0.992	0.000
G30.1 Alzheimer's disease with late onset	0.007	0.993	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.007	0.993	0.000
T41.5 Therapeutic gases	0.007	0.993	0.000
T41.4 Anaesthetic, unspecified	0.007	0.993	0.000
T41.3 Local anaesthetics	0.007	0.993	0.000
T41.2 Other and unspecified general anaesthetics	0.007	0.993	0.000
T41.1 Intravenous anaesthetics	0.007	0.993	0.000
T41.0 Inhaled anaesthetics	0.007	0.993	0.000
T49.9 Topical agent, unspecified	0.007	0.993	0.000
T49.8 Other topical agents	0.007	0.993	0.000
T49.7 Dental drugs, topically applied	0.007	0.993	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.007	0.993	0.000
T49.5 Ophthalmological drugs and preparations	0.007	0.993	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.993	0.000
T49.3 Emollients, demulcents and protectants	0.007	0.993	0.000
T49.2 Local astringents and local detergents	0.007	0.993	0.000
T49.1 Antipruritics	0.007	0.993	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
J91 Pleural effusion in conditions classified elsewhere	0.000	0.993	0.007
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.007	0.993	0.000
I77.1 Stricture of artery	0.007	0.993	0.000
M96.0 Pseudarthrosis after fusion or arthrodesis	0.007	0.993	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.007	0.993	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.993	0.000
C92 Myeloid leukaemia	0.007	0.993	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.007	0.993	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.993	0.007
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.007	0.993	0.000
T39.0 Salicylates	0.007	0.993	0.000
C92.0 Acute myeloid leukaemia	0.007	0.993	0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.007	0.993	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.993	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.006	0.993	0.000
T48.4 Expectorants	0.006	0.993	0.000
T48.3 Antitussives	0.006	0.993	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.006	0.993	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.006	0.993	0.000
T48.0 Oxytocic drugs	0.006	0.993	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.007	0.993	0.000
C83.7 Burkitt's tumour	0.007	0.993	0.000
C92.9 Myeloid leukaemia, unspecified	0.007	0.993	0.000
F22.9 Persistent delusional disorder, unspecified	0.006	0.993	0.000
T38.9 Other and unspecified hormone antagonists	0.006	0.993	0.000
T38.7 Androgens and anabolic congeners	0.006	0.993	0.000
T38.5 Other oestrogens and progestogens	0.006	0.993	0.000
T38.4 Oral contraceptives	0.006	0.993	0.000
T38.2 Antithyroid drugs	0.006	0.993	0.000
T38.0 Glucocorticoids and synthetic analogues	0.006	0.993	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.993	0.007
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.006	0.993	0.000
F22.8 Other persistent delusional disorders	0.006	0.993	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.006	0.994	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.006	0.994	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.994	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.006	0.994	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.006	0.994	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.006	0.994	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.006	0.994	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.006	0.994	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.006	0.994	0.000
T44.0 Anticholinesterase agents	0.006	0.994	0.000
C83.5 Lymphoblastic (diffuse)	0.006	0.994	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.994	0.000
E83.3 Disorders of phosphorus metabolism	0.001	0.994	0.006
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.006	0.994	0.000
C83.1 Small cleaved cell (diffuse)	0.006	0.994	0.000
T38.1 Thyroid hormones and substitutes	0.006	0.994	0.000
T48.5 Anti-common-cold drugs	0.006	0.994	0.000
C81 Hodgkin's disease	0.006	0.994	0.000
C83.6 Undifferentiated (diffuse)	0.006	0.994	0.000
C83.4 Immunoblastic (diffuse)	0.006	0.994	0.000
C83.2 Mixed small and large cell (diffuse)	0.006	0.994	0.000
T39.4 Antirheumatics, not elsewhere classified	0.006	0.994	0.000
T39.2 Pyrazolone derivatives	0.006	0.994	0.000
C85.1 B-cell lymphoma, unspecified	0.006	0.994	0.000
C92.7 Other myeloid leukaemia	0.006	0.994	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.006	0.994	0.000
C92.4 Acute promyelocytic leukaemia	0.006	0.994	0.000
C83.0 Small cell (diffuse)	0.006	0.994	0.000
O14.9 Preeclampsia, unspecified	0.000	0.994	0.006
T45.2 Vitamins, not elsewhere classified	0.005	0.994	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.995	0.000
T45.4 Iron and its compounds	0.005	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.995	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.005	0.995	0.000
C95 Leukaemia of unspecified cell type	0.005	0.995	0.000
C94 Other leukaemias of specified cell type	0.005	0.995	0.000
C88 Malignant immunoproliferative diseases	0.005	0.995	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.005	0.995	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.005	0.995	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.005	0.995	0.000
C92.3 Myeloid sarcoma	0.005	0.995	0.000
C92.2 Subacute myeloid leukaemia	0.005	0.995	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
C85.0 Lymphosarcoma	0.005	0.995	0.000
C81.9 Hodgkin's disease, unspecified	0.005	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.995	0.000
C92.5 Acute myelomonocytic leukaemia	0.005	0.995	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
C93 Monocytic leukaemia	0.005	0.995	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.005	0.995	0.000
M79.0 Rheumatism, unspecified	0.000	0.995	0.005
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.000	0.995	0.005
C84 Peripheral and cutaneous T-cell lymphomas	0.005	0.995	0.000
C82.6 Cutaneous follicle centre lymphoma	0.005	0.995	0.000
C82.5 Diffuse follicle centre lymphoma	0.005	0.995	0.000
O14.0 Moderate preeclampsia	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
T50.4 Drugs affecting uric acid metabolism	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.005	0.995	0.000
C82.2 Large cell, follicular	0.005	0.995	0.000
C83.3 Large cell (diffuse)	0.005	0.995	0.000
K22.8 Other specified diseases of oesophagus	0.005	0.995	0.000
C81.1 Nodular sclerosis	0.005	0.995	0.000
N32.8 Other specified disorders of bladder	0.000	0.995	0.005
C86 Other specified types of T/NK-cell lymphoma	0.005	0.995	0.000
G96 Other disorders of central nervous system	0.005	0.995	0.000
C82.4 Follicular lymphoma grade IIIb	0.005	0.995	0.000
C95.0 Acute leukaemia of unspecified cell type	0.005	0.995	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.005	0.995	0.000
M79.08 Rheumatism, unspecified (Other)	0.000	0.995	0.005
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
M96.8 Other postprocedural musculoskeletal disorders	0.005	0.995	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.004	0.995	0.000
C81.3 Lymphocytic depletion	0.004	0.995	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.004	0.995	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.004	0.995	0.000
C81.0 Lymphocytic predominance	0.004	0.995	0.000
C81.7 Other Hodgkin's disease	0.004	0.996	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.996	0.004
F00 Dementia in Alzheimer's disease	0.004	0.996	0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.000	0.996	0.004
C84.5 Other and unspecified T-cell lymphomas	0.004	0.996	0.000
G96.9 Disorder of central nervous system, unspecified	0.004	0.996	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.004	0.996	0.000
T50.8 Diagnostic agents	0.004	0.996	0.000
C81.2 Mixed cellularity	0.004	0.996	0.000
C82.3 Follicular lymphoma grade IIIa	0.004	0.996	0.000
C94.7 Other specified leukaemias	0.004	0.996	0.000
C94.5 Acute myelofibrosis	0.004	0.996	0.000
C94.4 Acute panmyelosis	0.004	0.996	0.000
C94.3 Mast cell leukaemia	0.004	0.996	0.000
C94.2 Acute megakaryoblastic leukaemia	0.004	0.996	0.000
C94.1 Chronic erythraemia	0.004	0.996	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.004	0.996	0.000
C95.7 Other leukaemia of unspecified cell type	0.004	0.996	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.004	0.996	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.004	0.996	0.000
C88.7 Other malignant immunoproliferative diseases	0.004	0.996	0.000
C88.3 Immunoproliferative small intestinal disease	0.004	0.996	0.000
C88.2 Gamma heavy chain disease	0.004	0.996	0.000
C88.1 Alpha heavy chain disease	0.004	0.996	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.004	0.996	0.000
C96.8 Histiocytic sarcoma	0.004	0.996	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.004	0.996	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.004	0.996	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.004	0.996	0.000
C96.3 True histiocytic lymphoma	0.004	0.996	0.000
C96.2 Malignant mast cell tumour	0.004	0.996	0.000
C96.1 Malignant histiocytosis	0.004	0.996	0.000
C96.0 Letterer-Siwe disease	0.004	0.996	0.000
T92 Sequelae of injuries of upper limb	0.000	0.996	0.004
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.996	0.004
C90 Multiple myeloma and malignant plasma cell neoplasms	0.004	0.996	0.000
I77 Other disorders of arteries and arterioles	0.004	0.996	0.000
M96.5 Postradiation scoliosis	0.004	0.996	0.000
C95.9 Leukaemia, unspecified	0.004	0.996	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.004	0.996	0.000
D80 Immunodeficiency with predominantly antibody defects	0.000	0.996	0.004
C93.9 Monocytic leukaemia, unspecified	0.004	0.996	0.000
C93.7 Other monocytic leukaemia	0.004	0.996	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.004	0.996	0.000
C93.2 Subacute monocytic leukaemia	0.004	0.996	0.000
C93.0 Acute monocytic leukaemia	0.004	0.996	0.000
F01.9 Vascular dementia, unspecified	0.004	0.996	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.996	0.004
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
M79.04 Rheumatism, unspecified (Hand)	0.000	0.996	0.004
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.996	0.004
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.996	0.004
C82.0 Small cleaved cell, follicular	0.004	0.996	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.004	0.996	0.000
D62 Acute posthaemorrhagic anaemia	0.000	0.996	0.004
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.004	0.996	0.000
G96.8 Other specified disorders of central nervous system	0.004	0.996	0.000
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.004	0.996	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.004	0.996	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.004	0.996	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.004	0.996	0.000
C84.3 Lymphoepithelioid lymphoma	0.004	0.996	0.000
C84.2 T-zone lymphoma	0.004	0.996	0.000
C84.1 Sezary's diease	0.004	0.996	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.996	0.004
M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis or bone plate	0.004	0.996	0.000
M96.4 Postsurgical lordosis	0.004	0.996	0.000
M96.3 Postlaminectomy kyphosis	0.004	0.996	0.000
M96.2 Postradiation kyphosis	0.004	0.996	0.000
C93.1 Chronic monocytic leukaemia	0.004	0.996	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.000	0.996	0.004
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.996	0.000
C84.0 Mycosis fungoides	0.004	0.996	0.000
T92.9 Sequelae of unspecified injury of upper limb	0.000	0.996	0.004
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.996	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.996	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.996	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.996	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.996	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.996	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.000	0.996	0.004
T92.0 Sequelae of open wound of upper limb	0.000	0.996	0.004
C88.0 Waldenstrom's macroglobulinaemia	0.004	0.996	0.000
I77.9 Disorder of arteries and arterioles, unspecified	0.004	0.996	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.004	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.996	0.000
T45.5 Anticoagulants	0.003	0.996	0.000
D86 Sarcoidosis	0.000	0.996	0.004
D80-D89 Certain disorders involving the immune mechanism	0.000	0.996	0.004
C90.3 Solitary plasmacytoma	0.003	0.996	0.000
M87.91 Osteonecrosis, unspecified (Shoulder region)	0.003	0.996	0.000
M96.9 Postprocedural musculoskeletal disorder, unspecified	0.003	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.996	0.000
T79.7 Traumatic subcutaneous emphysema	0.000	0.997	0.003
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.000	0.997	0.003
K85.1 Biliary acute pancreatitis	0.003	0.997	0.000
D84 Other immunodeficiencies	0.000	0.997	0.003
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.000	0.997	0.003
C02.9 Tongue, unspecified	0.003	0.997	0.000
O14.2 HELLP syndrome	0.000	0.997	0.003
G96.0 Cerebrospinal fluid leak	0.003	0.997	0.000
R23.8 Other and unspecified skin changes	0.003	0.997	0.000
G72.9 Myopathy, unspecified	0.000	0.997	0.003
I77.2 Rupture of artery	0.003	0.997	0.000
I77.0 Arteriovenous fistula, acquired	0.003	0.997	0.000
D86.1 Sarcoidosis of lymph nodes	0.000	0.997	0.003
T92.4 Sequelae of injury of nerve of upper limb	0.000	0.997	0.003
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.000	0.997	0.003
D41.0 Kidney	0.000	0.997	0.003
I77.8 Other specified disorders of arteries and arterioles	0.003	0.997	0.000
M87.9 Osteonecrosis, unspecified	0.003	0.997	0.000
F22.0 Delusional disorder	0.003	0.997	0.000
D83 Common variable immunodeficiency	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
I77.3 Arterial fibromuscular dysplasia	0.003	0.997	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.997	0.003
N41.9 Inflammatory disease of prostate, unspecified	0.003	0.997	0.000
F01 Vascular dementia	0.003	0.997	0.000
I77.5 Necrosis of artery	0.003	0.997	0.000
I77.4 Coeliac artery compression syndrome	0.003	0.997	0.000
D86.3 Sarcoidosis of skin	0.000	0.997	0.003
D80.8 Other immunodeficiencies with predominantly antibody defects	0.000	0.997	0.003
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.997	0.003
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.000	0.997	0.003
D80.0 Hereditary hypogammaglobulinaemia	0.000	0.997	0.003
D82 Immunodeficiency associated with other major defects	0.000	0.997	0.003
D86.0 Sarcoidosis of lung	0.000	0.997	0.003
D58.0 Hereditary spherocytosis	0.003	0.997	0.000
D83.9 Common variable immunodeficiency, unspecified	0.000	0.997	0.003
C84.4 Peripheral T-cell lymphoma	0.003	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.997	0.003
M81.90 Osteoporosis, unspecified (Multiple sites)	0.000	0.997	0.003
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.000	0.997	0.003
O14.1 Severe preeclampsia	0.000	0.997	0.003
M96.65 Fracture of pelvis following insertion of orthopedic implant, joint prosthesis, or bone plate (Fx pelvis following insrt ortho implnt/prosth/bone plt)	0.003	0.997	0.000
M96.63 Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate	0.003	0.997	0.000
D84.8 Other specified immunodeficiencies	0.000	0.997	0.003
M87.97 Osteonecrosis, unspecified (Ankle and foot)	0.003	0.997	0.000
C90.2 Plasmacytoma, extramedullary	0.003	0.997	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.000	0.997	0.003
D84.9 Immunodeficiency, unspecified	0.000	0.997	0.003
D84.1 Defects in the complement system	0.000	0.997	0.003
D59 Acquired haemolytic anaemia	0.003	0.997	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.003	0.997	0.000
D59.1 Other autoimmune haemolytic anaemias	0.003	0.997	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.000	0.997	0.003
Z90.8 Acquired absence of other organs	0.003	0.997	0.000
D82.1 Di George's syndrome	0.000	0.997	0.003
F05 Delirium, not induced by alcohol and other psychoactive substances	0.003	0.997	0.000
D58 Other hereditary haemolytic anaemias	0.003	0.997	0.000
D59.9 Acquired haemolytic anaemia, unspecified	0.003	0.997	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.000	0.997	0.003
D81 Combined immunodeficiencies	0.000	0.997	0.003
C02.1 Border of tongue	0.003	0.997	0.000
R23.4 Changes in skin texture	0.003	0.997	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.997	0.003
H16.3 Interstitial and deep keratitis	0.003	0.997	0.000
H92.1 Otorrhoea	0.003	0.997	0.000
F05.9 Delirium, unspecified	0.003	0.997	0.000
N18 Chronic renal failure	0.003	0.997	0.000
M87.96 Osteonecrosis, unspecified (Lower leg)	0.003	0.997	0.000
C90.1 Plasma cell leukaemia	0.003	0.997	0.000
T90.9 Sequelae of unspecified injury of head	0.003	0.997	0.000
C91 Lymphoid leukaemia	0.003	0.997	0.000
E26.0 Primary hyperaldosteronism	0.000	0.997	0.003
M87.99 Osteonecrosis, unspecified (Site unspecified)	0.003	0.997	0.000
M87.94 Osteonecrosis, unspecified (Hand)	0.003	0.997	0.000
M87.93 Osteonecrosis, unspecified (Forearm)	0.003	0.997	0.000
M87.92 Osteonecrosis, unspecified (Upper arm)	0.003	0.997	0.000
M87.90 Osteonecrosis, unspecified (Multiple sites)	0.003	0.997	0.000
S01.3 Open wound of ear	0.000	0.997	0.003
I87.1 Compression of vein	0.003	0.997	0.000
G72 Other myopathies	0.000	0.997	0.003
D36.1 Peripheral nerves and autonomic nervous system	0.003	0.997	0.000
D58.9 Hereditary haemolytic anaemia, unspecified	0.003	0.997	0.000
D83.8 Other common variable immunodeficiencies	0.000	0.997	0.002
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.997	0.002
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.997	0.002
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.997	0.002
F01.8 Other vascular dementia	0.002	0.997	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.002	0.997	0.000
F01.2 Subcortical vascular dementia	0.002	0.997	0.000
F01.0 Vascular dementia of acute onset	0.002	0.997	0.000
S00.8 Superficial injury of other parts of head	0.003	0.997	0.000
M87.98 Osteonecrosis, unspecified (Other)	0.002	0.997	0.000
T79 Certain early complications of trauma, not elsewhere classified	0.000	0.997	0.003
D55-D59 Haemolytic anaemias	0.002	0.997	0.000
H21.0 Hyphaema	0.003	0.997	0.000
T79.8 Other early complications of trauma	0.000	0.997	0.003
H16 Keratitis	0.003	0.997	0.000
G30-G32 Other degenerative diseases of the nervous system	0.003	0.997	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.997	0.002
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.997	0.002
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.997	0.002
D82.2 Immunodeficiency with short-limbed stature	0.000	0.997	0.002
D82.0 Wiskott-Aldrich syndrome	0.000	0.997	0.002
C02 Malignant neoplasm of other and unspecified parts of tongue	0.003	0.997	0.000
K60.3 Anal fistula	0.003	0.997	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.002	0.997	0.000
H21 Other disorders of iris and ciliary body	0.003	0.997	0.000
F05.0 Delirium not superimposed on dementia, so described	0.002	0.997	0.000
H16.0 Corneal ulcer	0.002	0.997	0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.000	0.997	0.003
D86.9 Sarcoidosis, unspecified	0.000	0.997	0.002
T43.2 Other and unspecified antidepressants	0.002	0.997	0.000
C91.9 Lymphoid leukaemia, unspecified	0.002	0.998	0.000
K01.0 Embedded teeth	0.000	0.998	0.002
S50.9 Superficial injury of forearm, unspecified	0.002	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
D56.1 Beta thalassaemia	0.002	0.998	0.000
D59.4 Other nonautoimmune haemolytic anaemias	0.002	0.998	0.000
F05.8 Other delirium	0.002	0.998	0.000
N18.1 Chronic kidney disease, stage 1	0.002	0.998	0.000
D59.8 Other acquired haemolytic anaemias	0.002	0.998	0.000
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.002	0.998	0.000
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.002	0.998	0.000
D59.3 Haemolytic-uraemic syndrome	0.002	0.998	0.000
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.002	0.998	0.000
D59.0 Drug-induced autoimmune haemolytic anaemia	0.002	0.998	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.998	0.002
G72.4 Inflammatory myopathy, not elsewhere classified	0.000	0.998	0.002
D56 Thalassaemia	0.002	0.998	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.002	0.998	0.000
G72.0 Drug-induced myopathy	0.000	0.998	0.002
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
M19.1 Posttraumatic arthrosis of other joints	0.002	0.998	0.000
F07.0 Organic personality disorder	0.002	0.998	0.000
T79.5 Traumatic anuria	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
G72.1 Alcoholic myopathy	0.000	0.998	0.002
S50.0 Contusion of elbow	0.002	0.998	0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations